GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Raphas Co Ltd (XKRX:214260) » Definitions » Gross Margin %
中文

Raphas Co (XKRX:214260) Gross Margin %

: 39.74% (As of Dec. 2023)
View and export this data going back to 2019. Start your Free Trial

Gross Margin % is calculated as gross profit divided by its revenue. Raphas Co's Gross Profit for the three months ended in Dec. 2023 was ₩3,399 Mil. Raphas Co's Revenue for the three months ended in Dec. 2023 was ₩8,555 Mil. Therefore, Raphas Co's Gross Margin % for the quarter that ended in Dec. 2023 was 39.74%.


The historical rank and industry rank for Raphas Co's Gross Margin % or its related term are showing as below:

XKRX:214260' s Gross Margin % Range Over the Past 10 Years
Min: 33.01   Med: 46.05   Max: 58.75
Current: 45.16


During the past 10 years, the highest Gross Margin % of Raphas Co was 58.75%. The lowest was 33.01%. And the median was 46.05%.

XKRX:214260's Gross Margin % is ranked worse than
65.85% of 735 companies
in the Biotechnology industry
Industry Median: 59.86 vs XKRX:214260: 45.16

Raphas Co had a gross margin of 39.74% for the quarter that ended in Dec. 2023 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for Raphas Co was 4.30% per year.


Raphas Co Gross Margin % Historical Data

The historical data trend for Raphas Co's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raphas Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 45.41 35.26 46.83 46.69 45.16

Raphas Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 53.72 50.41 47.16 44.08 39.74

Competitive Comparison

For the Biotechnology subindustry, Raphas Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Raphas Co Gross Margin % Distribution

For the Biotechnology industry and Healthcare sector, Raphas Co's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Raphas Co's Gross Margin % falls into.



Raphas Co Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Raphas Co's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=12615.8 / 27935.888
=(Revenue - Cost of Goods Sold) / Revenue
=(27935.888 - 15320.062) / 27935.888
=45.16 %

Raphas Co's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=3399.4 / 8554.525
=(Revenue - Cost of Goods Sold) / Revenue
=(8554.525 - 5155.078) / 8554.525
=39.74 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Raphas Co  (XKRX:214260) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Raphas Co had a gross margin of 39.74% for the quarter that ended in Dec. 2023 => Competition eroding margins


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Raphas Co Gross Margin % Related Terms

Thank you for viewing the detailed overview of Raphas Co's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Raphas Co (XKRX:214260) Business Description

Traded in Other Exchanges
N/A
Address
62, Magokjungang 8-ro 1-gil, Gangseo-gu, Seoul, KOR, 07793
Raphas Co Ltd is engaged in the development of a drug delivery system. The company's products include Acropass, Cosmetics ODM, and Medical Contract Manufacturing Services. Its products are mostly used in biomedical products and all-natural cosmetic materials.

Raphas Co (XKRX:214260) Headlines

No Headlines